• Personal Stories

‘I constantly see research improving outcomes for patients’ – Richard’s story

Three years ago, Richard was diagnosed with testicular cancer, and was treated with surgery, radiotherapy and chemotherapy. Three years ago, Richard was diagnosed with testicular cancer, and was treated with surgery, radiotherapy and chemotherapy.

22 July 2016

• Science & Technology
• Health & Medicine

From one-eyed lambs to ‘targeted’ skin cancer drugs

Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance. Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.

21 July 2016

• Personal Stories

“Having cancer made it professional and personal” – Lauren’s story.

Last year Lauren was about to start a year of study abroad in Hong Kong when her mum Julie was diagnosed with breast cancer. Last year Lauren was about to start a year of study abroad in Hong Kong when her mum Julie was diagnosed with breast cancer.

20 July 2016

• Health & Medicine

Tackling hard-to-treat cancers – what, how and why?

Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours. Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.

20 July 2016

• Health & Medicine

Cancer Research UK boosts efforts to overcome deadliest cancer as rates climb

Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014. Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014.

20 July 2016

• Health & Medicine
• Science & Technology

Making a special case – how to boost brain tumour research

Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them. Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them.

19 July 2016

• Science & Technology

Advances in Wilms’ tumour treatment – how less became more

Find out how our researchers have helped lead to nine in 10 children surviving Wilms' tumour, a type of children's kidney cancer. Find out how our researchers have helped lead to nine in 10 children surviving Wilms' tumour, a type of children's kidney cancer.

19 July 2016

• Charity News

Last orders on cancer – Dryathlon September is back!

Cancer Research UK’s Dryathlon is challenging the nation to prove their willpower this September. Cancer Research UK’s Dryathlon is challenging the nation to prove their willpower this September.

19 July 2016

• Personal Stories

‘I don’t let anything beat me’ – Keith’s story

Keith Hubbard is just one of the stories featured in our Annual Review, highlighting the progress we’re making and our aims for the future. Keith Hubbard is just one of the stories featured in our Annual Review, highlighting the progress we’re making and our aims for the future.

18 July 2016

• Health & Medicine

Cancer number one cause of death in England and Wales

Cancer accounted for over a quarter (28%) of all registered deaths in 2015, according to figures released by the Office of National Statistics. Cancer accounted for over a quarter (28%) of all registered deaths in 2015, according to figures released by the Office of National Statistics.

14 July 2016

• Health & Medicine

More than a million could be living with undiagnosed lung or heart diseases

As many as 1.7 million people in the UK could be living with undiagnosed lung cancer, lung disease or heart disease, according to Public Health England. As many as 1.7 million people in the UK could be living with undiagnosed lung cancer, lung disease or heart disease, according to Public Health England.

14 July 2016

• Health & Medicine

Immunotherapy drugs show promise in a range of advanced blood cancers

People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial. People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial.

14 July 2016